Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus

Sang‐Hyun Ihm(The Catholic University of Korea Bucheon St. Mary's Hospital), Kyu-Bo Choi(Catholic University of Korea), Ho‐Joong Youn, Ki‐Bae Seung, Dong-Il Shin(Catholic University of Korea), Sung-Won Jang(Catholic University of Korea), Chul‐Soo Park(Catholic University of Korea), Jae‐Hyung Kim(Catholic University of Korea), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Kiyuk Chang(St. Mary's Hospital)
International Journal of Cardiology
November 1, 2007
10.1016/j.ijcard.2007.07.057
Cited by 47

Related Papers

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304